TMFUltraLong

Sean Williams

A Fool since 2010, and a graduate from UC San Diego with a B.A. in Economics, Sean specializes in the healthcare sector and investment planning. You'll often find him writing about Obamacare, marijuana, drug and device development, Social Security, taxes, retirement issues and general macroeconomic topics of interest.

TMFUltraLong’s Activity

Thu May 26

NL

Article

TMFUltraLong published an article 12:00 AM

Another Month, Another 3 Reasons to Avoid Valeant Pharmaceuticals

Keeping your distance from Valeant continues to look like a smart decision.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Value Stocks Near 52-Week Lows Worth Buying

These three value stocks may be down, but they're far from out.

Wed May 25

NL

Article

TMFUltraLong published an article 12:00 AM

This New Data Could Push Exelixis' Cabometyx Over $1 Billion in Peak Annual Sales

A new label indication could be in Cabometyx's future after Exelixis reveals encouraging data in the CABOSUN study.

NL

Article

TMFUltraLong published an article 12:00 AM

Interested in Medivation? Take a Number!

Up to seven Big Pharma and biotech blue-chip companies could make a bid for Medivation.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Small-Cap Value Stocks to Power Your Portfolio

With PEG ratios well below one, these small-cap value stocks could be screaming buys.

Tue May 24

NL

Article

TMFUltraLong published an article 12:00 AM

Bet You Can't Guess Which of These 10 Big Pharma Names Has the Largest Late-Stage Pipeline

Phase 3 data is the bread and butter of all drugmaker catalysts. Find out which Big Pharma stock has a surprisingly large late-stage pipeline.

NL

Article

TMFUltraLong published an article 12:00 AM

Gold and Silver Stocks Get Slammed, but They're Looking Fundamentally Fabulous

Metal miners face another meltdown on rate hike fears, but this could represent a good buying opportunity for investors.

Mon May 23

NL

Article

TMFUltraLong published an article 12:00 AM

6 Ways Regulators Could Tackle the High Cost of Cancer Drugs

Cancer drug costs are soaring -- could one of these solutions keep these drugs affordable for the average American?

NL

Article

TMFUltraLong published an article 12:00 AM

Social Security Isn't an Entitlement -- Here's How to Qualify for Benefits

If you want to be covered by Social Security, here's what you'll need to do.

NL

Article

TMFUltraLong published an article 12:00 AM

Could You Cope With a 21% Cut to Your Retirement Income?

If Social Security is a major source of your current or expected retirement income, you could be in for a rude awakening.

NL

Article

TMFUltraLong published an article 12:00 AM

Billionaires Lightened Their Load on These 3 Widely-Held Stocks in Q1

Billionaire money managers reduced their holdings in these popular stocks last quarter, but was it a smart move?

NL

Article

TMFUltraLong published an article 12:00 AM

3 Attractive Income Stocks Whose Dividends Could Double

Want bigger dividend payouts? These three stocks may soon oblige.

NL

Article

TMFUltraLong published an article 12:00 AM

4 Safe Stocks With Dividend Yields Above 5%

Below-average volatility and above-average yields are music to dividend investors' ears.

Fri May 20

NL

Article

TMFUltraLong published an article 12:00 AM

A Staggering Number of U.S. Households Can't Cover a $1,000 Emergency Expense, Survey Shows

Are you among the majority of American households that would struggle to pay an unexpected bill?

Thu May 19

NL

Article

TMFUltraLong published an article 12:00 AM

Guess Who Just Sued the Federal Government Over Obamacare

This lawsuit could open the floodgates to additional legal action.

NL

Article

TMFUltraLong published an article 12:00 AM

3 Types of Stocks You'll Probably Want to Own as Interest Rates Rise

With the Federal Reserve on the precipice of further monetary tightening, here are three types of stocks to consider buying.

NL

Article

TMFUltraLong published an article 12:00 AM

Cancer Immunotherapies Take Center Stage in Pre-ASCO Abstract Releases

Big Pharma is out with encouraging cancer-survival data and response rates prior to the June ASCO event.

Wed May 18

NL

Article

TMFUltraLong published an article 12:00 AM

Can You Guess Which Gold Miner Has the Lowest All-in Sustaining Costs?

This leading low-cost miner's AISC forecast is nearly $500 an ounce below the current spot gold price.

NL

Article

TMFUltraLong published an article 12:00 AM

These 4 Value Stocks Are Collectively Generating $114 Billion in Free Cash Flow a Year

Want an easy way to potentially shield yourself from market volatility? Consider these four companies for your portfolio.

Tue May 17

NL

Article

TMFUltraLong published an article 2:18 PM

3 Perfect Stocks for Retirees in Their 60s to Consider Buying

Sporting a nice blend of market-topping dividend income and growth potential, these stocks could be perfect for new retirees.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 99.88
Player Rank 94 out of 74878
Score 9009.49
Score Change Today -36.07
Accuracy 88.53%
Active Picks 98
Total Picks 506
Best Pick FAZ (+314.73)
Worst Pick PCYC.DL (-8878.78)
Average Score per Pick 17.95
Charms Earned 16
Highest Rated Favorite TMFBabo
Go to TMFUltraLong’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 3
Recs Received 11
People who have rec'd these posts 11
Recs to Posts Ratio (last 30 days) N/A
Threads Started 2
Threads Started Percentage 66.67 %
Most Frequent Board CAPS Feedback
Very First Post Tickering....Just a heads up... (10/14/2010)
Percentage of Posts Rec'd 100.00 %
Show TMFUltraLong’s 10 Latest Posts